{"nct_id":"NCT02137772","title":"Letermovir (MK-8228) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001)","status":"COMPLETED","status_verified_date":"2019-08","start_date":"2014-06-06","start_date_type":"ACTUAL","primary_completion_date":"2016-08-08","primary_completion_date_type":"ACTUAL","completion_date":"2016-11-21","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["MRK"]}